
Javier Lopez Belmonte
Vice Chairman and CFO of Laboratorios Farmacéuticos ROVI; CEO of ROIS, a pharmaceutical CDMO company.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
Jun 23, 2026
Javier Lopez Belmonte, Vice Chairman, Rovi Group. Chief Executive Officer, ROIS.
3:34
6:01

Sam McElroyHOST
And would you say that was a natural transition then from the pharmaceutical background and I guess the roots that had been laid down by your grandfather in the 40s? Was that a natural transition into this service industry and CDMO or were there sort of changes that needed to be made to the business?
3:55
Well, I would say that we have the know-how, we have the internal know-how.
4:00
And that was, you know, when you're talking about injectables, aseptic filling, to have the right know-how, I think, is the most important item.
4:09
However, providing services to customer, you know, it's a different thing.
4:18
So that's why since the very beginning, we tried to separate the business to a different, you know, group of people.

Sam McElroyHOST
Was it always, was that always going to happen? Was it a kind of natural thing for you or were there options outside of the?
